Medtronic raised its fiscal-year outlook after logging higher profit and sales in its latest quarter, boosted by robust demand across end markets and healthy procedure volumes.

Silver slips near key support as gold weakens and Fed rate-cut odds fall, with traders watching major U.S. data for clues on sentiment and short-term direction.

The Goldman Sachs Conviction List is a curated list of stocks that the firm's research team believes have a high likelihood of outperforming the market.

LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The DJS Law Group reminds investors of a class action lawsuit against Jasper Therapeutics, Inc. (“Jasper” or “the Company”) (NASDAQ: JSPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of JSPR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

Certara, Inc. ( CERT ) Jefferies London Healthcare Conference 2025 November 18, 2025 5:30 AM EST Company Participants William Feehery - CEO & Director Conference Call Participants David Windley - Jefferies LLC, Research Division Presentation David Windley Jefferies LLC, Research Division Okay. Good morning, everybody.

PIRAEUS, Greece, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Navios Maritime Partners L.P. (“Navios Partners”) (NYSE: NMM), an international owner and operator of dry cargo and tanker vessels, today reported its financial results for the third quarter and nine month period ended September 30, 2025.

Micron (MU) is positioned to benefit from a DRAM supply crunch driven by surging AI demand, supporting a continued boom phase into FY26. MU's stock has more than doubled in the past year, and a significant supply shortage is expected to persist until new capacity ramps up in FY27. Despite stretched valuations, MU remains a strong momentum play, with a buy rating justified by robust revenue and margin growth forecasts through FY26.

Social media platform X was down for thousands of users in the US, according to Downdetector.

DeFi Development Corp (DFDV) remains a Buy, now trading at a significant discount to NAV after a 54% stock price decline. DFDV's SOL-focused treasury model generates strong staking yields, with Q3 revenue up 648% year-over-year and SPS accumulation continuing to grow. Recent developments include a warrant-based dividend, preferred stock offering, and the launch of a Treasury Accelerator program to drive future growth.

Topgolf Callaway Brands said it will sell a 60% stake in its Topgolf unit to private-equity firm Leonard Green as it turns more focus to its equipment and apparel business.

VanEck Steel ETF will soon switch benchmarks to the MVSLX Index. MVSLX lacks exposure to several emerging markets projected to drive significant steel sector growth over the next 1-2 years. MVSLX is heavily biased towards large market-cap companies and includes companies with significant non-steel business exposure.

Palantir (Nasdaq: PLTR) stock has lost 10% in the last 5 days after fading AI enthusiasm and negativity surrounding insider sales have caught up with a premium valuation.

ATLANTA--(BUSINESS WIRE)--Vestis (NYSE: VSTS), a leading provider of uniforms and workplace supplies, today announced that it will issue its fiscal fourth quarter and full year 2025 results after the market closes on Monday, December 1, 2025. A conference call will be held the following day, Tuesday, December 2, 2025 at 8:30 a.m. ET to review the Company's financial results and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will b.

Data demonstrate a favorable bioavailability profile of INM-901 oral formulation Data will support design and planning of first in human clinical trials Preparing for pre-IND meeting with the FDA Vancouver, British Columbia--(Newsfile Corp. - November 18, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company developing a pipeline of proprietary small-molecule drug candidates for diseases with high unmet medical needs, today announced the successful completion of pharmacokinetic ("PK") studies in large animal models for its Alzheimer's disease candidate INM-901. This marks the first preclinical study in which the oral formulation of INM-901 was administered in …

Shares of the buy-now, pay-later provider have tumbled since its public trading debut in September.

Collaboration accelerates quantum simulations by orders of magnitude, expanding global access to hybrid quantum computing and advancing the path toward industrial-scale quantum systems GPU-Accelerated QLEO Launch: QPerfect and Quobly unveil the next-generation QLEO emulator, powered by QPerfect's MIMIQ engine and fully compatible with NVIDIA CUDA-Q, delivering up to 100× faster quantum simulations. Bridging Quantum and Classical Systems: The collaboration expands access to hybrid quantum-classical computing, enabling developers and researchers to design, test, and scale quantum algorithms seamlessly across GPU and CPU environments.

AZOUR, Israel , Nov. 18, 2025 /PRNewswire/ -- Ituran Location and Control Ltd. (NASDAQ: ITRN) announced that the Board of Directors approved the distribution of a cash dividend in the amount of $0.50 per share, totaling approximately US$ 10 million.

Investors are starting to worry about too much AI-related debt issuance

PETACH TIKVA, Israel , Nov. 18, 2025 /PRNewswire/ -- Eltek Ltd. (NASDAQ: ELTK), a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards (PCBs), today announced its financial results for the quarter ended September 30, 2025.

CLEARWATER, Fla., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced the pricing of its previously announced underwritten public offering of 2,762,431 shares of its common stock at a public offering price of $3.62 per share of common stock, before deducting underwriting discounts and commissions and offering expenses.